🇰🇷 South Korea Country × Condition
heart failure Clinical Trials in South Korea
Active clinical trials for heart failure with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 4 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇰🇷 South Korea
Active Trials in South Korea (4)
NCT04899479 Phase 4
Recruiting
Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention
Enrollment
200 pts
Country
🇰🇷 South Korea
Samsung Medical Center
View Trial → NCT05672836 Phase 4
Recruiting
ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
Enrollment
1,040 pts
Country
🇰🇷 South Korea
Duk-Woo Park, MD
View Trial → NCT06243653
Recruiting
Relationship Between Coronary Microvascular Dysfunction and Improvement of Left Ventricular Systolic Function in Patients With Heart Failure With Reduced Ejection Fraction Caused by Non-ischemic Etiology
Enrollment
200 pts
Country
🇰🇷 South Korea
Samsung Medical Center
View Trial → NCT07002164
Recruiting
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
Enrollment
780 pts
Country
🇰🇷 South Korea
Chonnam National University Hospita...
View Trial → Frequently Asked Questions
How many heart failure clinical trials are active in South Korea?
There are currently 4 active clinical trials for heart failure with sites in South Korea, of which 4 are actively recruiting patients.
How can I join a heart failure clinical trial in South Korea?
To join a heart failure clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are heart failure trials in South Korea?
Active heart failure trials in South Korea span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.